Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Wedding Cake** is a named cannabis chemovar rather than a single standardized pharmaceutical product. It is generally described as a high-THC, low-CBD hybrid marijuana strain, commonly reported to descend from Triangle Kush and Animal Mints, although lineage descriptions can vary across commercial cannabis sources. Its pharmacology is therefore driven primarily by **delta-9-tetrahydrocannabinol acting as a partial agonist at cannabinoid receptor type 1 and cannabinoid receptor type 2**, with potential contribution from minor cannabinoids and terpenes. Because \"Wedding Cake\" refers to a strain name used in the cannabis market and not to one regulated, compositionally fixed drug product, potency, exact chemotype, manufacturer, formulation, route, and medical use claims are variable and non-standardized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wedding Cake.